A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)

NCT05441852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1151

Last updated 2023-07-14

No results posted yet for this study

Summary

The purpose of this study is to validate the real-world performance of a previously developed Artificial Intelligence - Electrocardiogram (AI-ECG) algorithm for identification of hyperkalemia with a six-lead mobile-enhanced device .

Conditions

  • Hyperkalemia

Sponsors & Collaborators

Principal Investigators

  • John Dillon, MD · Mayo Clinic

Eligibility

Min Age
50 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2023-07-07
Completion
2023-07-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05441852 on ClinicalTrials.gov